EndoTODAY | EndoATLAS | Outpatient Clinic
Parasite | Esophagus | Stomach | Cancer | ESD
Home | Guide | Author | Subscription | Links
[Thursday Endoscopy Conference 20161006]
ESD°¡ ½ÃÇàµÇ¾ú°í ¾Æ½±°Ô deep SM invasion°ú lymphatic invasionµµ µ¿¹ÝµÇ¾î ÀÖ¾î ¼ö¼úÀ» ÇÏ¿´°í no residual tumor°¡ ³ª¿Ô½À´Ï´Ù.
2. Local recurrence after ESD for EGC (EGC with SM invasion, mixed histology)
1) ESD ÈÄ ÃßÀû°Ë»ç¿¡¼ À°¾È¼Ò°ßÀÌ Á¤»ó scarÀÎ °æ¿ì´Â Àç¹ßÀÎ ¿¹°¡ °ÅÀÇ ¾ø½À´Ï´Ù. ±×·¯³ª Ç¥¸éÀÇ ºÒ±ÔÄ¢¼ºÀ̳ª ¹ßÀû µîÀÇ ¼Ò°ßÀÌ º¸ÀÌ¸é ±¹¼ÒÀç¹ßÀ» °í·ÁÇÏ¿© Á¶½É½º·´°Ô Á¶Á÷°Ë»ç¸¦ ÇÒ ÇÊ¿ä°¡ ÀÖ½À´Ï´Ù.
2) ¹ÌºÐÈ È¥Àç¾ÏÀÎ °æ¿ì º´¼ÒÀÇ °æ°è¸¦ Á¤Çϱ⠾î·Æ½À´Ï´Ù. ESD ÈÄ resection margin involvement°¡ Àְųª ÀýÀç ¿©ºÐÀÌ ÃæºÐÇÏÁö ¾ÊÀ» ¼ö ÀÖ½À´Ï´Ù (EndoTODAY lateral margin involvement). ±× °á°ú local recurÀÇ È®·üÀÌ ³ôÀ» °ÍÀ¸·Î »ý°¢ÇÕ´Ï´Ù (°ü·Ã ¿¬±¸ ÀÚ·á´Â ¾ø½À´Ï´Ù¸¸...)
* Âü°í: EndoTODAY ESD ÈÄ ±¹¼Ò Àç¹ß
3. Local recurrence after esophageal cancer surgery
70´ë ¿©¼ºÀÔ´Ï´Ù.
ÀÏ°ß ½ÉÇغ¸ÁöÁö ¾Ê´Â ½Äµµ¾ÏÀÌ ¹ß°ßµÇ¾ú½À´Ï´Ù. ±×·¯³ª EUS¿¡¼´Â proper muscle invasionÀÌ ÀǽɵǾú½À´Ï´Ù.
5ÁÖ ÈÄ Àç°ËÀÔ´Ï´Ù. ºñ±³Àû »¡¸® ÀÚ¶ó´Â ½Äµµ¾ÏÀ¸·Î ÆǴܵǾú½À´Ï´Ù. ¸²ÇÁÀý ÀüÀ̵µ ÀǽɵǾú½À´Ï´Ù.
¼ö¼ú (3 hole operation) ÈÄ º´¸®°á°ú´Â »ý°¢º¸´Ù ½ÉÇß½À´Ï´Ù. Adjuvant FOLFOX#6 ½ÃÇàÇÏ¿´½À´Ï´Ù.
Esophagus and upper stomach, Ivor Lewis operation:
Invasive squamous cell carcinoma, well differentiated :
1) tumor size: 6.1x4.3 cm
2) extension to periesophageal soft tissue (adventitia)
3) endolymphatic tumor emboli: not identified
4) perineural invasion: not identified
5) resection margins: free from carcinoma, safety margin: proximal, 3.5 cm ; distal, 5 cm; circumferential (adventitial) margin(deep), < 50 §
6) metastasis to 1 out of 41 regional lymph nodes (right recurrent laryngeal nerve LN, 1/3)
7) treatment effect: no prior treatment
3³â ÈÄ gastric tube¿¡¼ SMT-like º´¼Ò°¡ ¹ß°ßµÇ¾ú½À´Ï´Ù. °âÀÚ Á¶Á÷°Ë»ç´Â ƯÀ̼ҰßÀÌ ¾ø¾ú½À´Ï´Ù.
4°³¿ù ÈÄ Àç°Ë¿¡¼ SMT-like º´¼Ò¿¡ ±íÀº ±Ë¾çÀÌ Çü¼ºµÇ¾ú½À´Ï´Ù. °âÀÚ Á¶Á÷°Ë»ç¿¡¼ squamous cell carcinoma·Î È®ÀεǾú½À´Ï´Ù. ±¹¼ÒÀç¹ß·Î CCRT¸¦ ½ÃÇàÇÏ¿´½À´Ï´Ù.
* ±èÀçÁØ ±³¼ö´Ô comment: Àü ³»½Ã°æ¿¡¼´Â ¾ø¾ú´ø SMT À¯»ç º´¼Ò°¡ intrathoracic stomach¿¡¼ ¹ß°ßµÇ¾ú±â ¶§¹®¿¡ Åë»óÀÇ SMT°¡ ¾Æ´Ï¶ó ½Äµµ¾ÏÀÇ ±¹¼Ò Àç¹ßÀ» °í·ÁÇØ¾ß ÇÕ´Ï´Ù. ³»½Ã°æ ½ÃÇà Àǻ簡 ³»½Ã°æ °á°úÁö¿¡ EUS-guided biopsy¸¦ ÃßõÇß´õ¶ó¸é ´õ ÁÁ¾ÒÀ» °Í °°½À´Ï´Ù.
* Âü°í: EsoTODAY ½Äµµ¾Ï ±¹¼Ò Àç¹ß
4. DLBCL after liver transplantation
°£°æº¯À¸·Î °£ÀÌ½Ä ½ÃÇà¹ÞÀº ȯÀÚÀÇ º¹Åë.
Ascending colon, cecum, appendix, and terminal ileum, extended right hemicolectomy:
Post-transplant lymphoproliferative disorder, diffuse large B cell lymphoma
1. Location: ascending colon
2. Gross type: ulceroinfiltrative
3. Size: 5x2.5 cm
4. Depth of invasion: invades subserosa or pericolic/perirectal adipose tissue (pT3)
5. Resection margin: free from carcinoma, safety margin: proximal, 11 cm ; distal, 30 cm
6. Regional lymph node metastasis : Involvement in 2 out of 27 regional lymph nodes(pN1b)
7. Pathologic staging: pT3 N1b
Cardia cancer´Â ´Ã »ý°¢º¸´Ù ½ÉÇÕ´Ï´Ù.
Stomach, total gastrectomy:
Advanced gastric carcinoma
1. Location : upper third, Center at cardia
2. Gross type : Borrmann type (unclassifiable) (mimicking EGC type IIc)
3. Histologic type : tubular adenocarcinoma, poorly (poorly cohesive) differentiated
4. Histologic type by Lauren : diffuse
5. Size : 2.5x2.4 cm
6. Depth of invasion : invades muscularis propria (pT2)
7. Resection margin: free from carcinoma, safety margin: proximal 1 cm, distal 18 cm
8. Lymph node metastasis : metastasis to 1 out of 33 regional lymph nodes (pN1) ("9", 1/4)
9. Lymphatic invasion : present
10. Venous invasion : not identified
11. Perineural invasion : present
12. AJCC stage by 7th edition: T2 N1
1) SMC Endoscopy Unit »ï¼º¼¿ïº´¿ø ³»½Ã°æ½Ç
2) SMC Monday GI conference »ï¼º¼¿ïº´¿ø ÀÏ¿ø³»½Ã°æ±³½Ç ¿ù¿äÁ¡½É¼ÒȱâÁý´ãȸ
3) SMC Thursday endoscopy conference »ï¼º¼¿ïº´¿ø ÀÏ¿ø³»½Ã°æ±³½Ç ¸ñ¿äÁ¡½É³»½Ã°æÁý´ãȸ
© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng.